Joseph L. Dowling III - 04 Jun 2021 Form 4 Insider Report for Cano Health, Inc.

Role
Chief Executive Officer
Signature
/s/ Michael Racich, as attorney-in-fact for Joseph L. Dowling
Issuer symbol
N/A
Transactions as of
04 Jun 2021
Net transactions value
+$525,000
Form type
4
Filing time
07 Jun 2021, 18:28:17 UTC
Previous filing
21 May 2021
Next filing
02 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CANO Class A common stock Award $525,000 +52,500 $10.00 52,500 04 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Joseph L. Dowling III is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The reporting person purchased 52,500 shares of Class A common stock from Cano Health (as defined below) in a private placement that closed concurrently with the consummation of the transactions contemplated by the Business Combination Agreement, dated November 11, 2020, by and among Jaws Acquisition Corp. ("Jaws"), Primary Care (ITC) Intermediate Holdings, LLC ("PCIH"), and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), whereby Jaws domesticated as a Delaware corporation (the "Domestication") and changed its name to "Cano Health, Inc." ("Cano Health").